DiscoverStartupsTruckee Applied GenomicsTruckee Applied Genomics Funding Rounds, Valuation & Investors
Tools removing critical blockers to molecular dx: insufficient DNA, RNA, proteins1-10 Employees
- B2B
- Early StageStartup in initial stages
Truckee Applied Genomics Funding
$3M
11 round
Truckee Applied Genomics is active in the following markets / industries: biotechnology, synthetic biology, bioinformatics, bio pharm, breast cancer, Medical Technologies, Digital Pathology and genomics. The company has secured funding across 1 rounds, totaling in an amount of $3M. Their most recent funding was raised on July 7, 2021.
Funding Rounds
PRE
$3000000Investors of Truckee Applied Genomics
CEO, Truckee Applied Genomics. Advisor to Cardiac Motion and Cardiac Patterns. Life science investor. Avid skier (Tahoe) and eMTB enthusiast.